Find Academic Supervisors

• Exercise Oncology
• Cancer Rehabilitation
• Prostate Cancer Treatment
• +3 more

Professor Daniel Galvão is a leading academic in exercise oncology at Edith Cowan University (ECU), Australia. He serves as Director of the Exercise Medicine Research Institute and holds a Professorship in Exercise and Sports Science within the School of Medical and Health Sciences. His research focuses on optimizing exercise interventions to mitigate treatment-related toxicities and improve outcomes for cancer patients, particularly those with prostate cancer. Galvão has secured over $26 million in grants from bodies like the NHMRC, Movember Foundation, and Cancer Australia, supporting multidisciplinary trials and survivorship programs. Education: PhD (Edith Cowan University, 2006), Master of Applied Science in Clinical Exercise Science (University of Queensland, 2003). His career includes roles as Co-Director of ECU’s Health and Wellness Institute and Fellowships with the American College of Sports Medicine and Exercise and Sports Science Australia. Research emphasizes exercise as medicine in oncology, with over 200 peer-reviewed publications. Key contributions include guidelines for exercise in cancer patients and landmark trials like ERADICATE (prostate cancer radiotherapy adjuncts) and TelEX (weight management for prostate cancer). Notable awards include the 2021 Asian Pacific Prostate Cancer Conference Best Poster, 2014 Edith Cowan Vice-Chancellor’s Award, and 2007 ESSA PhD Medal. He chairs national research committees and reviews for high-impact journals like Journal of Clinical Oncology and European Urology . Current initiatives include nationwide exercise programs for prostate cancer survivors and translational research on myokine mechanisms in cancer suppression. His work bridges clinical practice with evidence-based interventions to enhance patient quality of life and survival outcomes.

Elin GrayView profile

Professor

• Cancer Biology
• Liquid Biopsy
• Melanoma
• +3 more

Professor Elin Gray is Deputy Director of the Centre for Precision Health at Edith Cowan University (ECU) and leads the Translational Melanoma Research Group. She holds a Cancer Council of Western Australia Research Fellowship and specializes in liquid biopsies for cancer diagnosis. Her research explores circulating tumor cells, ctDNA, and extracellular vesicles to monitor tumor evolution and therapy resistance. Education: Doctor of Philosophy (2008, South Africa) Master in Biochemistry (2001, Cuba) Bachelor of Biochemistry (1997, Cuba) Her work bridges immunology, virology, and oncology, with emphases on melanoma biomarkers, immunotherapy resistance mechanisms, and exercise-induced tumor suppression. Recent studies leverage spatial transcriptomics and single-cell genomics to dissect tumor microenvironments. She has secured significant grants including NHMRC funding for liquid biopsy development ($820,889) and leads the Western Australia Melanoma Initiative ($1.16M). Her team collaborates globally to translate findings into clinical practice. Awards: Cancer Council of Western Australia Research Fellowship Professor Gray mentors 25+ graduate students and postdoctoral researchers, focusing on CTC isolation, TCR repertoire analysis, and extracellular vesicle diagnostics. Her laboratory pioneers multimodal liquid biopsies for real-time cancer monitoring.

• Exercise Oncology
• Cancer Rehabilitation
• Tumor Biology
• +5 more

Professor Rob Newton is a leading academic at Edith Cowan University (ECU) as the Professor of Exercise Medicine and founder of the Exercise Medicine Research Institute . He holds concurrent appointments as Vice-Chancellor Professorial Research Fellow in 2020 and has dedicated his career to integrating exercise as neoadjuvant, adjuvant, and rehabilitative therapy for cancer patients. His research spans exercise oncology, tumor biology, body composition, and quality of life in cancer care. He earned a Doctor of Science (DSc, 2021) PhD in Human Movement Studies (1998) Master of Human Movement Studies (1986) Bachelor of Human Movement Studies (Hons, 1986) from the University of Queensland and Southern Cross University. His recent work focuses on exercise-induced myokines , resistance training modalities , and exercise’s impact on cancer progression , with trends observed in breast, prostate, and ovarian cancers . Many studies employ systematic reviews, meta-analyses, and randomized controlled trials to evaluate exercise prescriptions. Scientific Awards : Career Achievement Award (2018) - Cancer Council WA Western Australia Premier’s Scientist of the Year (2019) With a Scopus h-index of 90 and over $45M in research funding , Newton leads interdisciplinary collaborations across oncology, sports science, and clinical exercise physiology . His lab has pioneered exercise medicine protocols for cancer patients, including the ERADICATE trial for prostate cancer and EXPAN trial for pancreatic cancer.

• Exercise Oncology
• Cancer Immunology
• Breast Cancer
• +5 more

Dr. Helene Rundqvist is a Senior Researcher at the Department of Laboratory Medicine, Karolinska Institutet, where she combines basic science research in Exercise Oncology with patient intervention studies. She serves as co-PI of two H2020-funded exercise oncology clinical trials, PREFERABLE EFFECT and PREFERABLE LION, leading multinational research efforts to understand how structured exercise affects outcomes for patients with metastatic breast cancer. Dr. Rundqvist earned her PhD in Physiology from Karolinska Institutet in 2008, building on her foundational degree in Molecular Biology. Her postdoctoral training included significant work at the University of California, San Diego, studying immune contributions to metastasis, and at Karolinska Institutet's Department of Oncology and Pathology, investigating exercise interventions in cancer models. Her research demonstrates that exercise interventions reduce symptom burden, enhance physical functioning, and improve health-related quality of life for cancer patients. A significant portion of her work focuses on immune surveillance mechanisms, particularly how exercise mobilizes cytotoxic T-cells and NK-cells to control solid tumor progression. Her current efforts involve detailed characterization of immune cell metabolism, homing capabilities, and antitumoral effects in both animal models and patients with advanced breast cancer. Analysis of Dr. Rundqvist's recent publications (2024-2025) reveals a comprehensive research program spanning clinical trials (particularly the PREFERABLE series), immune mechanisms, cardiovascular effects of cancer treatment, and quality of life outcomes. A consistent theme is the investigation of exercise-induced immune cell mobilization and function, with growing attention to health economic analyses evaluating the cost-effectiveness of exercise interventions in cancer care. Dr. Rundqvist has extensive teaching experience across all academic levels, delivering instruction in Statistics, Physiology, Immunology, Cell Biology, Tumor Microenvironment, and Metabolism. She leads a 5-week course in Scientific Theory and Statistics at Karolinska Institutet and supervises graduate students and postdoctoral fellows. Her research is supported by significant Horizon 2020 funding for the PREFERABLE EFFECT and PREFERABLE LION trials, which investigate structured exercise programs for metastatic breast cancer patients. Dr. Rundqvist's laboratory work combines basic science approaches with clinical applications, focusing on immune cell characterization following exercise interventions using both animal models and patient samples. Her research bridges molecular mechanisms with practical clinical applications, requiring close collaboration across oncology, immunology, and exercise physiology disciplines to investigate how exercise affects cancer progression and patient outcomes.

• Physics Education
• Climate Change Science
• Radiation Physics
• +3 more

Dr. George Takacs serves as an Honorary Fellow at the School of Physics, University of Wollongong, Australia, with his current appointment dating from 2020 to present. His academic profile demonstrates significant contributions across multiple domains of physics research and education. Dr. Takacs' research interests span physics education (particularly climate change science education), medical physics, radiation therapy, and dosimetry. His work in physics education focuses on developing effective teaching methods for pre-service teachers and understanding student conceptions of scientific concepts, especially in climate change education. In medical physics, his research centers on radiation therapy techniques, dosimetry systems, and the application of magnetic fields in radiotherapy. Analysis of his publication record reveals a clear trajectory from fundamental physics research toward applied medical physics and science education. His recent publications emphasize educational applications, particularly in climate change science education, while maintaining connections to his earlier work in medical physics and radiation detection. Dr. Takacs has secured research funding through multiple competitive grants, including the Discovery Projects grant 'Radiation Protection for Space, Aviation, and Terrestrial Applications' (2006-2009) and the 'Radio-magneto-therapy' project (2006). His research collaborations extend across institutions, with frequent co-authorship with researchers like A.B. Rosenfeld, M.L.F. Lerch, and L. Jarrett. Supervised numerous higher degree research students across diverse topics including climate change education, medical physics, and radiation therapy Contributed to development of educational tools like the concept inventory for climate change science Involved in practical medical physics applications including urethral dosimetry systems for prostate cancer treatment His current research activities include supervising PhD candidates investigating climate science topics and continuing work at the intersection of physics education and medical physics applications.

Timothy Van HaitsmaView profile

Associate Professor

• Exercise Physiology
• Fitness and Health
• Chronic Fatigue Syndrome
• +3 more

Dr. Timothy Van Haitsma is an Associate Professor of Kinesiology at Westmont. He holds a Ph.D. in Exercise Physiology from the University of Utah, an M.S. from Indiana University, and a B.S. from Calvin College. His research focuses on exercise-induced fatigue mechanisms, chronic fatigue syndrome, and the interplay between mental training and physical performance. He teaches courses in human physiology and clinical exercise physiology. Key research interests include: Physiological and psychological underpinnings of exercise fatigue Mind-body interactions in athletic performance Gene expression profiling in fatigue-related conditions His recent work explores mental training's physiological effects, heat stress impacts on cyclists, and biomarker identification for fatigue states. He has published over 30 peer-reviewed articles spanning exercise science, clinical physiology, and sports medicine. Professional service includes advising Westmont's Kinesiology program and maintaining an active research lab investigating human performance optimization. His outdoor interests align with his professional focus on endurance sports physiology.

Kjetil Wessel AndressenView profile

Associate Professor

• Pharmacology
• Heart Failure
• Cellular Signal Transduction
• +7 more

Kjetil Wessel Andressen is an Associate Professor in the Department of Pharmacology at the Faculty of Medicine, University of Oslo. He is actively involved in research on heart failure, cellular signal transduction, and the development of new pharmacological targets for HFrEF and HFpEF. His work integrates molecular pharmacology, biosensor technology, and cardiac physiology. Andressen holds a Cand. Pharm. (2002) and a PhD (2008), both from the University of Oslo. His research focuses on GPCR signaling, cAMP and cGMP dynamics, and compartmentalized signaling in cardiomyocytes, with an emphasis on natriuretic peptides and phosphodiesterase regulation. He has developed and applied FRET-based biosensors to visualize real-time signaling events. His recent publications reveal a strong trend in understanding spatial organization of cyclic nucleotide signaling in cardiac cells, particularly in disease states. His work bridges molecular mechanisms with therapeutic implications in heart failure and receptor pharmacology. Member, Norwegian Society for Pharmacology and Toxicology Leader of Section of Pharmacology (2012–2016) Scientific Awards: No specific awards mentioned in the provided text. He advises no listed students but collaborates extensively with national and international researchers, including those from Oxford, Hamburg, Baylor College of Medicine, and Karolinska Institutet. He is involved in the Center for Heart Failure Research at Oslo University Hospital (OUS) and leads research groups on compartmentation of cardiac signaling and receptor pharmacology.

• Urology
• Urolithiasis
• Benign Prostatic Hyperplasia
• +3 more

Prof. Dr. Ramazan KOCAASLAN is a Professor in the Department of Urology, Faculty of Medicine at Kafkas University. His academic journey includes a Bachelor's from Istanbul University Cerrahpasa Faculty of Medicine (1995-2003), a medical specialization from Istanbul Training and Research Hospital (2003-2008), and an Associate Degree in Law from Anadolu University (2017-2020). He holds certifications in robotic surgery (Da Vinci) and multilingual proficiency (English YDS:71, German YDS:83). His research focuses on urological conditions including urolithiasis, benign prostatic hyperplasia, erectile dysfunction, and minimally invasive surgical techniques. He explores innovative diagnostic and therapeutic approaches, often incorporating pharmacological and surgical interventions. KOCAASLAN's publications emphasize evidence-based urology, with recent work analyzing surgical techniques for kidney stones, biomarkers for urinary infections, and medical therapies for urological disorders. His research frequently employs randomized trials and retrospective analyses to evaluate clinical outcomes. Awards & Honors: TÜYK Sertifikası (Turkish Urology Association, 2009) THE GPIU Study (European Association of Urology, 2008) EUREP (European Urology Residents Education Programme, 2006) He has led one major research project on renal cell carcinoma biomarkers (2013-2015) and collaborates extensively with urology researchers nationally. No formal advising roles or lab affiliations are documented.

• Clinical Exercise Physiology
• Chronic Disease Management
• Exercise and Cancer Survivorship
• +9 more

John Saxton is Professor of Clinical Exercise Physiology at the School of Rehabilitation Sciences, University of East Anglia (UEA), a position he has held since March 2010. He also holds an honorary role as Honorary Visiting Research Fellow at Sheffield Hallam University. His career spans academic and research leadership across multiple institutions, including Oxford Brookes University, the University of Sheffield, and Sheffield Hallam University, where he led the Active Health Research Group. His educational background includes a degree from Loughborough University (1990) and PhD research in skeletal muscle physiology at the University of Wolverhampton and the University of Massachusetts at Amherst, USA. Professor Saxton’s research centers on the role of exercise and lifestyle interventions in the prevention and management of age-related chronic conditions, including cancer, cardiovascular disease, peripheral vascular disease, chronic heart failure, and multiple sclerosis. His work aims to optimize exercise therapy and understand differential patient responses. He has secured major research funding from bodies such as the British Heart Foundation, Cancer Research UK, the American Institute for Cancer Research, and the Multiple Sclerosis Society. His recent publications, including the 2024 article on exercise sustainability post-colorectal surgery, reflect a strong focus on exercise oncology, prehabilitation, and recovery pathways. The articles collectively highlight interdisciplinary research spanning clinical rehabilitation, patient experience, biomarker analysis, and implementation science, with a recurring emphasis on evidence-based interventions and long-term health outcomes. His scientific contributions include editing key texts such as Exercise and Cancer Survivorship (2010) and Exercise and Chronic Disease (2011), and contributing numerous book chapters and invited reviews. He is an editorial board member of Clinical Science and a Fellow of the British Association of Sport and Exercise Sciences. Professor Saxton has supervised seven PhD students to completion and currently mentors five doctoral candidates across UEA and Sheffield Hallam University. He has led funded projects such as the PREPARE-ABC trial and the MS Society study on exercise therapy. He previously served as Associate Dean for Enterprise and Engagement (2010–2012) and continues as Director of Learning and Teaching Quality (Postgraduate Research) since 2011. He has been involved in expert panels including the Breast Cancer Campaign Research Gap Analysis, the Multiple Sclerosis International Federation Consensus Meeting, and the UK Physical Activity Guidelines Consensus Meeting, demonstrating national and international leadership in shaping public health policy.

Shawn FlanaganView profile

Associate Professor

• Free Radical Biology
• Stress Response Mechanisms
• Nutrition Physiology
• +3 more

Shawn Flanagan serves as an Associate Professor of Instruction in the Department of Health and Human Physiology within the College of Liberal Arts and Sciences at the University of Iowa. He teaches foundational and advanced courses spanning human physiology, pathophysiology, immunology, nutrition, and aging, including HHP:1300 Fundamentals of Human Physiology and HHP:5300 Advanced Human Physiology. Dr. Flanagan earned his PhD in Integrative Physiology from the University of Iowa. His research investigates free radical biology in health and disease, with emphasis on stress response mechanisms and nutritional impacts across whole-organism, cellular, and molecular levels. This work bridges physiological adaptation, oxidative stress pathways, and disease pathogenesis, particularly in neurodegenerative conditions like ALS. His experimental approaches integrate molecular techniques with whole-animal models to dissect cytoprotective mechanisms. Analysis of his publications reveals a chronological evolution from 1990s heat-shock protein studies in thermotolerance and prostate cancer to 2000s investigations of superoxide dismutase in ALS models. His work consistently centers on oxidative stress mechanisms, demonstrating how free radical flux influences cellular survival in disease contexts across physiology, biochemistry, and neuroscience disciplines. His scientific recognition includes: NRSA Institutional Pre-doctoral training fellowship (1991-1994) Gatorade student research grant (1994-1995) NRSA Institutional Post-doctoral training fellowship (1997-1999) Two Young Investigator Awards from the Oxygen Society (2000, 2001) Dr. Flanagan's research has been supported by NIH training grants and industry partnerships, with collaborative work spanning the Department of Internal Medicine and University of Iowa Center on Aging. His mentorship extends through classroom instruction and laboratory research guidance for undergraduate and graduate students in health sciences. His laboratory collaborations focus on oxidative stress mechanisms, particularly with the Oberley research group on superoxide dismutase function in neurodegenerative models and with urology researchers on thermal ablation techniques for prostate cancer.

• Health Psychology
• Social Psychology
• Chronic Illness
• +3 more

Tracey Revenson, PhD, is a Professor of Psychology at Hunter College and the Graduate Center of the City University of New York (CUNY). She holds a BA from Yale University in Theatre and Psychology, a PhD in Psychology from New York University, and postdoctoral training in Social Ecology from the University of California, Irvine. Her research focuses on stress, coping processes, and social support in the context of chronic illness, emphasizing the influence of gender, race/ethnicity, and socioeconomic status. She leads the CHiC (Coping and Health in Context) Lab, investigating psychosocial adaptation in families facing illnesses like cancer and rheumatoid arthritis. Education: Bachelor of Arts: Yale University (Theatre and Psychology) PhD: New York University (Psychology) Postdoctoral Training: University of California, Irvine (Social Ecology) Her research adopts a social-ecological perspective, examining how contextual factors shape health outcomes. Key areas include decision-making in cancer care, disparities in healthcare experiences, and interventions to improve coping. She has published over 200 peer-reviewed articles and co-authored/co-edited 13 books, including major handbooks in health psychology. Research Projects: NIH-funded studies on decision tools for Latinx cancer patients regarding tumor genetic profiling. Investigations into stress and adjustment among younger adults with blood cancers. Qualitative studies on cultural beliefs and exercise adherence in Bengali families with hypertension. Awards: Nathan Perry Award for Career Contributions to Health Psychology (2013) Fellowships in multiple societies: APA, Society for Behavioral Medicine, European Health Psychology Society Mentoring awards from Society for Health Psychology and Society for Behavioral Medicine Editorial Roles: Editor-in-Chief of Annals of Behavioral Medicine Past Editor-in-Chief of International Journal of Behavioral Medicine CHiC Lab: Focuses on brief interventions to enhance quality of life in chronic illness, including sleep hygiene programs and studies on skin disease stigma. The lab actively recruits research assistants with coursework in health psychology or disparities.

Cheng-Bang ChenView profile

Assistant Professor

• Artificial Intelligence in Healthcare
• Biomechanics
• Functional Data Analysis
• +4 more

Cheng-Bang Chen is an Assistant Professor in the College of Engineering at the University of Miami. His work bridges artificial intelligence, biomedical engineering, and data science with applications in healthcare diagnostics, surgical outcomes analysis, and biomechanics. He holds an ORCiD identifier (0000-0003-0025-6447) and can be reached via cxc1920@miami.edu. Research interests focus on developing AI-driven solutions for medical imaging (e.g., prostate cancer diagnosis enhancement), surgical metrics optimization (RVU/operative time correlations), and complex systems analysis using recurrence quantification methods. His multidisciplinary approach integrates machine learning with traditional engineering domains like energy systems and supply chain configurations. Recent publications (2023-2025) emphasize AI ethics in healthcare, novel surgical outcome prediction models, and biomechanical studies involving weightlifting techniques. He explores synthetic data generation to address algorithmic bias in medical diagnostics and develops advanced neural network architectures for predictive analytics. Awards and grants sections remain under development pending additional profile information. Current work involves collaborations across engineering, medical, and data science domains at the University of Miami.

• Exercise Oncology
• Cardiorespiratory Fitness
• Strength Training
• +2 more

Tormod Skogstad Nilsen is an Associate Professor at the Department of Sport Science and Physical Education , University of Agder. His work bridges Exercise Physiology and Oncology , focusing on the effects of physical activity in cancer populations and muscle adaptation mechanisms. Research Interests: Cardiorespiratory fitness in cancer survivors Muscle cellular stress and adaptions Strength training during androgen deprivation therapy Blood flow restriction training Chronobiology in resistance exercise Publication Trends: His recent studies (2025-2008) emphasize randomized controlled trials in breast and prostate cancer populations, systematic reviews in exercise oncology, and molecular adaptations to resistance training. Key themes include cardiovascular risk reduction, epigenetic changes post-cancer, and time-of-day training effects. Collaborations: He works extensively with multidisciplinary teams across Scandinavia and North America, contributing to journals like JACC: CardioOncology , Medicine & Science in Sports & Exercise , and Acta Oncologica .

• Prostate Cancer
• Bone Metastases
• Exercise Oncology
• +3 more

Marta Kramer Mikkelsen serves as an Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, with clinical operations based at Copenhagen University Hospital (Rigshospitalet), Blegdamsvej 3, Copenhagen. Her research specializes in exercise-based interventions for oncology patients, particularly investigating high-intensity resistance and impact training protocols for individuals with hormone-sensitive prostate cancer experiencing bone metastases. This work bridges clinical oncology and physical therapy to address skeletal complications and improve functional outcomes. Her recent publication (2025) details a randomized clinical trial protocol examining exercise efficacy for bone metastasis management, reflecting her focus on evidence-based physical rehabilitation in cancer care. This study represents emerging trends in exercise oncology targeting skeletal health preservation during hormone therapy.

• Cancer Genetics
• Breast Cancer
• Epidemiology
• +3 more

Dr. Saundra S. Buys is a Professor in the Department of Internal Medicine at the University of Utah School of Medicine. She specializes in Medical Oncology and Hematology, with board certifications from the American Board of Internal Medicine in these subspecialties. Education: MD from Tufts University; B.S. from Northeastern University; Internship, Residency, and Hematology/Oncology Fellowship at University of Utah School of Medicine. Her research focuses on cancer genetics , breast cancer risk assessment , epidemiology , and genetic counseling . Recent work includes studies on digital health tools for genetic services (BRIDGE trial), social vulnerability in genetic service utilization, and physical activity's impact on early-onset breast cancer risk. Publications highlight collaborations in precision oncology , hereditary cancer registries , and genetic variant analysis . She leads trials comparing chatbot vs standard genetic education models and investigates gene-environment interactions in BRCA carriers. Patient testimonials emphasize her compassionate care , professional expertise , and holistic approach to treatment. Reviews consistently praise her timeliness, thoroughness, and patient-centered communication at Huntsman Cancer Center and Sugar House Health Center.